Skip to content

Validation and evaluation of a gene set classifier for late radiation toxicity in prostate cancer patients

Validation and evaluation of a gene set classifier for late radiation toxicity in prostate cancer patients - Late radiation toxicity AMC & LUMC

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32354
Enrollment
200
Registered
2008-07-01
Start date
2008-05-27
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Adult patients with prostate cancer who will have curative external beam radiotherapy, - Proficient in Dutch - Written informed consent

Exclusion criteria

Exclusion criteria: - Patients who had prostatectomy, iodine-125 brachytherapy or radiotherapy for recurrent disease - Patients with psychosocial or somatic disorders in the medical history, limiting the possibilities for adequate follow-up

Design outcomes

Primary

MeasureTime frame
-

Secondary

MeasureTime frame
-

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)